Copyright Reports & Markets. All rights reserved.

Global Veterinary/Animal Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Request for Sample of this report
Buy now

Table of Contents

    Global Veterinary/Animal Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2023

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 Veterinary/Animal Vaccines Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Product Type Market

      • 2.1 World Product Type Market Performance and Trend
        • 2.1.1 World Market Performance
        • 2.1.2 Different Type of Market Performance
      • 2.2 North America Product Type Market Performance and Trend
        • 2.2.1 North America Market Performance
        • 2.2.2 Different Type of Market Performance
      • 2.3 Europe Product Type Market Performance and Trend
        • 2.3.1 Europe Market Performance
        • 2.3.2 Different Type of Market Performance
      • 2.4 Asia-Pacific Product Type Market Performance and Trend
        • 2.4.1 Asia-Pacific Market Performance
        • 2.4.2 Different Type of Market Performance
      • 2.5 South America Product Type Market Performance and Trend
        • 2.5.1 South America Market Performance
        • 2.5.2 Different Type of Market Performance
      • 2.6 Middle East and Africa Product Type Market Performance and Trend
        • 2.6.1 Middle East and Africa Market Performance
        • 2.6.2 Different Type of Market Performance

      3 Product Application Market

      • 3.1 World Product Application Market Performance and Trend
        • 3.1.1 World Market Performance
        • 3.1.2 Different Applications of Market Trend
      • 3.2 North America Product Application Market Performance and Trend
        • 3.2.1 North America Market Performance
        • 3.2.2 Different Applications of Market Trend
      • 3.3 Europe Product Application Market Performance and Trend
        • 3.3.1 Europe Market Performance
        • 3.3.2 Different Applications of Market Trend
      • 3.4 Asia-Pacific Product Application Market Performance and Trend
        • 3.4.1 Asia-Pacific Market Performance
        • 3.4.2 Different Applications of Market Trend
      • 3.5 South America Product Application Market Performance and Trend
        • 3.5.1 South America Market Performance
        • 3.5.2 Different Applications of Market Trend
      • 3.6 Middle East and Africa Product Application Market Performance and Trend
        • 3.6.1 Middle East and Africa Market Performance
        • 3.6.2 Different Applications of Market Trend

      4 Manufacturers Profiles/Analysis

      • 4.1 Zoetis Inc. (Pfizer)
        • 4.1.1 Zoetis Inc. (Pfizer) Profiles
        • 4.1.2 Zoetis Inc. (Pfizer) Product Information
        • 4.1.3 Zoetis Inc. (Pfizer) Veterinary/Animal Vaccines Business Performance
        • 4.1.4 Zoetis Inc. (Pfizer) Veterinary/Animal Vaccines Business Development and Market Status
      • 4.2 Merck Animal Health
        • 4.2.1 Merck Animal Health Profiles
        • 4.2.2 Merck Animal Health Product Information
        • 4.2.3 Merck Animal Health Veterinary/Animal Vaccines Business Performance
        • 4.2.4 Merck Animal Health Veterinary/Animal Vaccines Business Development and Market Status
      • 4.3 Merial Inc.
        • 4.3.1 Merial Inc. Profiles
        • 4.3.2 Merial Inc. Product Information
        • 4.3.3 Merial Inc. Veterinary/Animal Vaccines Business Performance
        • 4.3.4 Merial Inc. Veterinary/Animal Vaccines Business Development and Market Status
      • 4.4 Boehringer Ingelheim
        • 4.4.1 Boehringer Ingelheim Profiles
        • 4.4.2 Boehringer Ingelheim Product Information
        • 4.4.3 Boehringer Ingelheim Veterinary/Animal Vaccines Business Performance
        • 4.4.4 Boehringer Ingelheim Veterinary/Animal Vaccines Business Development and Market Status
      • 4.5 Bayer Animal Health
        • 4.5.1 Bayer Animal Health Profiles
        • 4.5.2 Bayer Animal Health Product Information
        • 4.5.3 Bayer Animal Health Veterinary/Animal Vaccines Business Performance
        • 4.5.4 Bayer Animal Health Veterinary/Animal Vaccines Business Development and Market Status
      • 4.6 Elanco Animal Health
        • 4.6.1 Elanco Animal Health Profiles
        • 4.6.2 Elanco Animal Health Product Information
        • 4.6.3 Elanco Animal Health Veterinary/Animal Vaccines Business Performance
        • 4.6.4 Elanco Animal Health Veterinary/Animal Vaccines Business Development and Market Status
      • 4.7 Ceva Animal Health
        • 4.7.1 Ceva Animal Health Profiles
        • 4.7.2 Ceva Animal Health Product Information
        • 4.7.3 Ceva Animal Health Veterinary/Animal Vaccines Business Performance
        • 4.7.4 Ceva Animal Health Veterinary/Animal Vaccines Business Development and Market Status
      • 4.8 Heska Corporation
        • 4.8.1 Heska Corporation Profiles
        • 4.8.2 Heska Corporation Product Information
        • 4.8.3 Heska Corporation Veterinary/Animal Vaccines Business Performance
        • 4.8.4 Heska Corporation Veterinary/Animal Vaccines Business Development and Market Status
      • 4.9 Virbac Inc.
        • 4.9.1 Virbac Inc. Profiles
        • 4.9.2 Virbac Inc. Product Information
        • 4.9.3 Virbac Inc. Veterinary/Animal Vaccines Business Performance
        • 4.9.4 Virbac Inc. Veterinary/Animal Vaccines Business Development and Market Status

      5 Market Performance for Manufacturers

      • 5.1 Global Veterinary/Animal Vaccines Sales (K Units) and Market Share by Manufacturers 2013-2018
      • 5.2 Global Veterinary/Animal Vaccines Revenue (M USD) and Market Share by Manufacturers 2013-2018
      • 5.3 Global Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
      • 5.4 Global Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
      • 5.5 Market Concentration

      6 Regions Market Performance for Manufacturers

      • 6.1 North America Market Performance for Manufacturers
        • 6.1.1 North America Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.1.2 North America Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.1.3 North America Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
        • 6.1.4 North America Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
        • 6.1.5 Market Concentration
      • 6.2 Europe Market Performance for Manufacturers
        • 6.2.1 Europe Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.2.2 Europe Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.2.3 Europe Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
        • 6.2.4 Europe Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
        • 6.2.5 Market Concentration
      • 6.3 Asia-Pacific Market Performance for Manufacturers
        • 6.3.1 Asia-Pacific Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.3.2 Asia-Pacific Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.3.3 Asia-Pacific Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
        • 6.3.4 Asia-Pacific Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
        • 6.3.5 Market Concentration
      • 6.4 South America Market Performance for Manufacturers
        • 6.4.1 South America Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.4.2 South America Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.4.3 South America Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
        • 6.4.4 South America Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
        • 6.4.5 Market Concentration
      • 6.5 Middle East and Africa Market Performance for Manufacturers
        • 6.5.1 Middle East and Africa Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.5.2 Middle East and Africa Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.5.3 Middle East and Africa Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
        • 6.5.4 Middle East and Africa Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
        • 6.5.5 Market Concentration

      7 World Market Performance Point

      • 7.1 World Veterinary/Animal Vaccines Sales (K Units) and Share by Regions and Countries 2013-2018
        • 7.1.1 World Veterinary/Animal Vaccines Sales (K Units) and Share by Regions 2013-2018
        • 7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.1 Asia-Pacific Veterinary/Animal Vaccines Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.2 North America Veterinary/Animal Vaccines Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.3 Europe Veterinary/Animal Vaccines Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.4 South America Veterinary/Animal Vaccines Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.5 Middle East and Africa Veterinary/Animal Vaccines Sales (K Units) and Share by Countries 2013-2018
      • 7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018
        • 7.2.1 World Revenue (M USD) and Share by Regions 2013-2018
        • 7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.1 Asia-Pacific Veterinary/Animal Vaccines Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.2 North America Veterinary/Animal Vaccines Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.3 Europe Veterinary/Animal Vaccines Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.4 South America Veterinary/Animal Vaccines Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.5 Middle East and Africa Veterinary/Animal Vaccines Revenue (M USD) and Share by Countries 2013-2018
      • 7.3 World Price (USD/Unit) by Regions and Countries 2013-2018
        • 7.3.1 World Price (USD/Unit) by Regions 2013-2018
        • 7.3.2 Regional Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.1 Asia-Pacific Veterinary/Animal Vaccines Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.2 North America Veterinary/Animal Vaccines Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.3 Europe Veterinary/Animal Vaccines Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.4 South America Veterinary/Animal Vaccines Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.5 Middle East and Africa Veterinary/Animal Vaccines Price (USD/Unit) by Countries 2013-2018
      • 7.4 World Gross Margin by Regions and Countries 2013-2018
        • 7.4.1 World Gross Margin by Regions 2013-2018
        • 7.4.2 Regional Gross Margin and Share by Countries 2013-2018
          • 7.4.2.1 Asia-Pacific Veterinary/Animal Vaccines Gross Margin and Share by Countries 2013-2018
          • 7.4.2.2 North America Veterinary/Animal Vaccines Gross Margin and Share by Countries 2013-2018
          • 7.4.2.3 Europe Veterinary/Animal Vaccines Gross Margin and Share by Countries 2013-2018
          • 7.4.2.4 South America Veterinary/Animal Vaccines Gross Margin and Share by Countries 2013-2018
          • 7.4.2.5 Middle East and Africa Veterinary/Animal Vaccines Gross Margin and Share by Countries 2013-2018

        8 Development Trend for Regions and Countries (Sales Point)

        • 8.1 World Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.3 North America Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.4 Europe Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.5 South America Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.6 Middle East and Africa Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018

        9 Upstream Source, Technology and Cost

        • 9.1 Upstream Source
        • 9.2 Technology
        • 9.3 Cost

        10 Channel Analysis

        • 10.1 Market Channel
        • 10.2 Distributors

        11 Consumer Analysis

        • 11.1 Inactivated Vaccines Industry
        • 11.2 Live Attenuated Vaccines Industry
        • 11.3 Toxoid Vaccines Industry

        12 Market Forecast 2019-2024

        • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
          • 12.1.1 Global Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
          • 12.1.2 Global Veterinary/Animal Vaccines Sales (K Units) and Growth Rate 2019-2024
          • 12.1.3 Asia-Pacific Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.4 Asia-Pacific Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.5 Europe Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.6 South America Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.7 Middle East and Africa Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024
          • 12.2.1 Overall Market Performance
          • 12.2.2 Livestock Diseases Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.3 Porcine Diseases Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.4 Poultry Diseases Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.5 Companion Animal Diseases Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 12.3 Sales by Application 2019-2024
          • 12.3.1 Overall Market Performance
          • 12.3.2 Inactivated Vaccines Sales and and Growth Rate 2019-2024
          • 12.3.3 Live Attenuated Vaccines Sales and and Growth Rate 2019-2024
          • 12.3.4 Toxoid Vaccines Sales and and Growth Rate 2019-2024
          • 12.3.5 Conjugate Vaccines Sales and and Growth Rate 2019-2024
        • 12.4 Price (USD/Unit) and Gross Profit
          • 12.4.1 Global Veterinary/Animal Vaccines Price (USD/Unit) Trend 2019-2024
          • 12.4.2 Global Veterinary/Animal Vaccines Gross Profit Trend 2019-2024

        13 Conclusion

      Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Veterinary/Animal Vaccines in these regions, from 2012 to 2023 (forecast), covering
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Columbia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
      Global Veterinary/Animal Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
      Zoetis Inc. (Pfizer)
      Merck Animal Health
      Merial Inc.
      Boehringer Ingelheim
      Bayer Animal Health
      Elanco Animal Health
      Ceva Animal Health
      Heska Corporation
      Virbac Inc.
      On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
      Livestock Diseases
      Porcine Diseases
      Poultry Diseases
      Companion Animal Diseases
      Equine Diseases
      Aquaculture Diseases
      Other
      On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Veterinary/Animal Vaccines for each application, including
      Inactivated Vaccines
      Live Attenuated Vaccines
      Toxoid Vaccines
      Conjugate Vaccines
      DNA Vaccines
      Recombinant Vaccines
      Subunit Vaccines

      If you have any special requirements, please let us know and we will offer you the report as you want.

      Buy now